We are live on
!
Find out more
HA
HHLR Advisors Portfolio holdings
AUM
$1.67B
1-Year Est. Return
7.53%
This Fund
S&P 500
This Quarter
Est. Return
+1.39%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$10.1B
AUM Growth
-$2.46B
(-20%)
Cap. Flow
-$2.33B
Cap. Flow
% of AUM
-23.06%
Top 10 Holdings %
Top 10 Hldgs %
66.26%
Holding
108
New
13
Increased
9
Reduced
29
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NBP
NovaBridge Biosciences American Depositary Shares
NBP
|
+$278M |
| 2 |
Playtika
PLTK
|
+$96.5M |
| 3 |
Instil Bio
TIL
|
+$61.2M |
| 4 |
TUYA
Tuya Inc
TUYA
|
+$52M |
| 5 |
BridgeBio Pharma
BBIO
|
+$42.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$864M |
| 2 |
Zoom
ZM
|
+$370M |
| 3 |
TAL Education Group
TAL
|
+$290M |
| 4 |
Uber
UBER
|
+$274M |
| 5 |
Bilibili
BILI
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.49% |
| 2 | Consumer Discretionary | 20.09% |
| 3 | Technology | 16.32% |
| 4 | Communication Services | 9.51% |
| 5 | Financials | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Instil Bio
TIL
$49.2M
| $59.8M | 0.59% |
+119,273
| New | +$61.2M |
|
27
Kiniksa Pharmaceuticals
KNSA
$6.12B
| $54M | 0.53% |
2,920,023
| – | – |
|
|
TUYA
28
Tuya Inc
TUYA
$1.04B
| $50.2M | 0.5% |
+2,375,000
| New | +$52M |
|
29
Affiliated Managers Group
AMG
$9.6B
| $49.9M | 0.49% |
335,073
| – | – |
|
30
Aligos Therapeutics
ALGS
$25.9M
| $49.2M | 0.49% |
86,603
| – | – |
|
|
AKRO
31
DELISTED
Akero Therapeutics
AKRO
| $48.1M | 0.47% |
1,656,673
| – | – |
|
32
TSMC
TSM
$1.95T
| $42.6M | 0.42% |
360,495
-40,000
| -10% | -$4.95M |
|
33
Otis Worldwide
OTIS
$27.7B
| $42.1M | 0.42% |
614,556
| – | – |
|
34
Melco Resorts & Entertainment
MLCO
$2.19B
| $33.8M | 0.33% |
1,698,877
| – | – |
|
35
Root
ROOT
$926M
| $33.1M | 0.33% |
144,444
| – | – |
|
36
Keurig Dr Pepper
KDP
$42.5B
| $33M | 0.33% |
960,154
-272,512
| -22% | -$8.83M |
|
37
Huazhu Hotels Group
HTHT
$13.3B
| $31.8M | 0.31% |
578,902
+21,800
| +4% | +$1.17M |
|
|
FMTX
38
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $30.8M | 0.3% |
1,100,000
| – | – |
|
39
Alibaba
BABA
$276B
| $30.8M | 0.3% |
+135,700
| New | +$33.3M |
|
40
Allogene Therapeutics
ALLO
$597M
| $28.2M | 0.28% |
800,000
| – | – |
|
41
Prelude Therapeutics
PRLD
$361M
| $27.1M | 0.27% |
626,502
-123,498
| -16% | -$8.19M |
|
|
CALT
42
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
| $26.1M | 0.26% |
944,716
-102,971
| -10% | -$3.08M |
|
43
Apple
AAPL
$5.01T
| $24.4M | 0.24% |
200,000
-100,000
| -33% | -$12.8M |
|
44
XPeng
XPEV
$12.5B
| $24M | 0.24% |
+658,595
| New | +$27.4M |
|
|
BEDU
45
DELISTED
Bright Scholar Education Holdings
BEDU
| $23.1M | 0.23% |
996,449
| – | – |
|
46
Olema Pharmaceuticals
OLMA
$983M
| $20.6M | 0.2% |
620,397
| – | – |
|
47
Axsome Therapeutics
AXSM
$11.7B
| $20.4M | 0.2% |
360,000
| – | – |
|
|
MOGU
48
MOGU Inc
MOGU
$17.3M
| $20.3M | 0.2% |
870,581
| – | – |
|
|
KRON
49
DELISTED
Kronos Bio
KRON
| $19.3M | 0.19% |
658,436
| – | – |
|
50
Legend Biotech
LEGN
$3.64B
| $18.9M | 0.19% |
650,000
| – | – |
|
Similar funds
TFS
GC
PA
LCI
JPM
NRI
CPO
JIP
HHLR Advisors's Q1 2021 Portfolio in Review
As of Q1 2021, HHLR Advisors held 108 positions worth $10.1B, down 20% from $12.6B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
HHLR Advisors withdrew a net $2.33B in Q1 2021, closing 17 positions and reducing 29 holdings. Its most notable exit was TAL Education Group, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, HHLR Advisors opened a new position in Playtika worth $89.3M.
- HHLR Advisors's largest Q1 2021 buy was Playtika: 3,280,699 shares worth $89.3M.
- HHLR Advisors added most to NovaBridge Biosciences American Depositary Shares in Q1 2021, an estimated $278M increase.
- HHLR Advisors's biggest Q1 2021 reduction was JD.com, cutting an estimated $864M.
- HHLR Advisors fully exited TAL Education Group in Q1 2021, selling an estimated $290M.
- HHLR Advisors's ten largest holdings make up 66% of its $10.1B portfolio in Q1 2021.
- HHLR Advisors opened 13 new positions and closed 17 in Q1 2021.
- HHLR Advisors's portfolio value fell 20% quarter-over-quarter to $10.1B.
Based on HHLR Advisors's 13F filing for Q1 2021, filed 17 May 2021.